Search
for
Sort by
Research 631–660 of 1000+
- Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Alopecia in Rats Fed Certain Soybean Oil Meal Rations.
- Radially patterned morphogenesis of murine hair follicle placodes ensures robust epithelial budding
- Influence of Chemical Straightening on the Stability of Drugs of Abuse in Hair
- 597 Outer root sheath is able to synthesise glycogen from lactate-investigating glycogen metabolism in human hair follicles
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Fat grafting of hairy areas of head and neck - comparison between lipofilling and nanofat grafting procedures in a cadaveric study
- Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Observations that suggest a contribution of altered dermal papilla mitochondrial function to androgenetic alopecia
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
- Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
- Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
- Health Issues Unique to the Aging Man
- Human Pilosebaceous Culture
- Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- 841 Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical Minoxidil
- Hair follicle culture—a historical perspective
- Models for Skin Cancer
- Hair Grafts in Lower Leg Reconstruction
- WHOLE HAIR FOLLICLE CULTURE
- Hair is a functionally graded composite, not a uniform fiber
- Hair is a functionally graded composite, not a uniform fiber
- P33 Quantification of metabolic pathways in human hair follicles and their response to caffeine and N,N-dimethylglycine